Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease

INTRODUCTION: The burden of metabolic (dysfunction) associated fatty liver disease (MAFLD) is rising mirrored by an increase in hepatocellular cancer (HCC). MAFLD and its sequelae are characterized by perturbations in lipid handling, inflammation, and mitochondrial damage. The profile of circulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haonan, George, Jacob, Eslam, Mohammed, Villanueva, Augusto, Bolondi, Luigi, Reeves, Helen L., McCain, Misti, Chambers, Edward, Ward, Caroline, Sartika, Dewi, Sands, Caroline, Maslen, Lynn, Lewis, Matthew R., Ramaswami, Ramya, Sharma, Rohini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982340/
https://www.ncbi.nlm.nih.gov/pubmed/36872928
http://dx.doi.org/10.1159/000525911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982340/
https://www.ncbi.nlm.nih.gov/pubmed/36872928
http://dx.doi.org/10.1159/000525911

Ejemplares similares